Park SA - Search Results

1

Amplifying glioblastoma immunotherapy: T cell shielding through Nitric oxide/reactive oxygen species scavenging nanoparticles Potentiates anti-PD-1.

Lee J, Kang Y, Lee H, Saravanakumar G, Park SA, Ahn S, Kim WJ. Lee J, et al. Among authors: park sa. Biomaterials. 2024 Oct 22;315:122904. doi: 10.1016/j.biomaterials.2024.122904. Online ahead of print. Biomaterials. 2024. PMID: 39490061

2

Intratumoral IL-12 delivery via mesenchymal stem cells combined with PD-1 blockade leads to long-term antitumor immunity in a mouse glioblastoma model.

Park J, Park SA, Kim YS, Kim D, Shin S, Lee SH, Jeun SS, Chung YJ, Ahn S. Park J, et al. Among authors: park sa. Biomed Pharmacother. 2024 Apr;173:115790. doi: 10.1016/j.biopha.2023.115790. Epub 2024 Mar 1. Biomed Pharmacother. 2024. PMID: 38431436 Free article.

3

Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma.

Han HR, Park SA, Ahn S, Jeun SS, Ryu CH. Han HR, et al. Among authors: park sa. Anticancer Res. 2019 Dec;39(12):6635-6643. doi: 10.21873/anticanres.13878. Anticancer Res. 2019. PMID: 31810928

4

Combination treatment with VPA and MSCs‑TRAIL could increase anti‑tumor effects against intracranial glioma.

Park SA, Han HR, Ahn S, Ryu CH, Jeun SS. Park SA, et al. Oncol Rep. 2021 Mar;45(3):869-878. doi: 10.3892/or.2021.7937. Epub 2021 Jan 14. Oncol Rep. 2021. PMID: 33469674 Free PMC article.

5

HLA polymorphisms and risk of glioblastoma in Koreans.

Choi SS, Choi H, Baek IC, Park SA, Park JS, Kim TG, Jeun SS, Ahn S. Choi SS, et al. Among authors: park sa, park js. PLoS One. 2021 Dec 9;16(12):e0260618. doi: 10.1371/journal.pone.0260618. eCollection 2021. PLoS One. 2021. PMID: 34882724 Free PMC article.

6

Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma.

Choi H, Baek IC, Park SA, Park JS, Jeun SS, Kim TG, Ahn S. Choi H, et al. Among authors: park sa, park js. J Clin Med. 2023 Jul 19;12(14):4780. doi: 10.3390/jcm12144780. J Clin Med. 2023. PMID: 37510895 Free PMC article.

7

Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands.

Choi H, Lee Y, Park SA, Lee JH, Park J, Park JH, Lee HK, Kim TG, Jeun SS, Ahn S. Choi H, et al. Among authors: park sa, park jh, park j. Oncoimmunology. 2022 Oct 30;11(1):2138152. doi: 10.1080/2162402X.2022.2138152. eCollection 2022. Oncoimmunology. 2022. PMID: 36338147 Free PMC article.

8

Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma.

Kim D, Park J, Park HC, Zhang S, Park M, Park SA, Lee SH, Lee YS, Park JS, Jeun SS, Chung YJ, Ahn S. Kim D, et al. Among authors: park sa, park hc, park js, park m, park j. Cancer Cell Int. 2024 Jan 18;24(1):36. doi: 10.1186/s12935-024-03225-4. Cancer Cell Int. 2024. PMID: 38238738 Free PMC article.

9

Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.

Kim SM, Oh JH, Park SA, Ryu CH, Lim JY, Kim DS, Chang JW, Oh W, Jeun SS. Kim SM, et al. Among authors: park sa. Stem Cells. 2010 Dec;28(12):2217-28. doi: 10.1002/stem.543. Stem Cells. 2010. PMID: 20945331

10

Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells.

Ryu CH, Park SH, Park SA, Kim SM, Lim JY, Jeong CH, Yoon WS, Oh WI, Sung YC, Jeun SS. Ryu CH, et al. Among authors: park sa, park sh. Hum Gene Ther. 2011 Jun;22(6):733-43. doi: 10.1089/hum.2010.187. Epub 2011 Mar 23. Hum Gene Ther. 2011. PMID: 21261460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

665 results

Search Page

Filters